3-hydroxykynurenine has been researched along with Infection, Toxoplasma gondii in 2 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Notably, the anti-parasitic drugs pyrimethamine and sulfadiazine, a standard treatment of toxoplasmosis, significantly reduced 3-HK and KYNA levels in the brain of infected mice when applied between 28 and 56 days post-infection." | 3.80 | Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. ( Fang, Q; Harris, TH; Horning, KJ; Hunter, CA; Notarangelo, FM; Schwarcz, R; Thomas, MA; Wilson, EH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vondroušová, J | 1 |
| Mikoška, M | 1 |
| Syslová, K | 1 |
| Böhmová, A | 1 |
| Tejkalová, H | 1 |
| Vacek, L | 1 |
| Kodym, P | 1 |
| Krsek, D | 1 |
| Horáček, J | 1 |
| Notarangelo, FM | 1 |
| Wilson, EH | 1 |
| Horning, KJ | 1 |
| Thomas, MA | 1 |
| Harris, TH | 1 |
| Fang, Q | 1 |
| Hunter, CA | 1 |
| Schwarcz, R | 1 |
2 other studies available for 3-hydroxykynurenine and Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Monitoring of kynurenine pathway metabolites, neurotransmitters and their metabolites in blood plasma and brain tissue of individuals with latent toxoplasmosis.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Hydroxyindoleacetic Acid; Kynurenine; Male; Ne | 2019 |
Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Topics: Animals; Anti-Infective Agents; Brain; Disease Models, Animal; Drug Combinations; Female; Kynurenic | 2014 |